AI Enhanced Trials
With Biostatistical Data Validation for
Researchers, Pharma, and Biotechs
With 90% of clinical trials facing less than a 30% chance of success and 60% failing due to inadequate design, the key challenge lies in learning from vast, complex datasets. Navigating over 468,429 trials globally, 114,925 conditions, 2.69 billion patients, and 608,400,000 data points, and thousands of medical journals requires advanced tools to extract meaningful, actionable insights.
TrialKey addresses this challenge as a global leader in data-driven biostatistical validation. Our platform utilises machine learning to analyse data from diverse sources, focusing on critical variables that drive trial success. By conducting up to 100,000 simulations per trial, TrialKey delivers robust virtual trial scenarios, identifying optimal design elements, including trial duration, and patient dropout rates.
Solutions for Optimal Clinical Trials
Design Optimal Trials
Using your study synopsis or protocol, we leverage AI to design clinical trials with the highest probability of success from the outset.
Optimise Existing Trials
Enhance ongoing trials by adjusting key parameters to minimise risks and reduce timelines.
Predict Outcomes
Accurately forecast trial results using advanced predictive analytics and real-world data.
Optimised Clinical Trial Design
TrialKey assists in selecting the optimal components for clinical trials by offering data-driven recommendations for:
- Study Structure
Define study type, timeline, arms, groups, and set precise primary and secondary endpoints. - Enrollment & Interventions
Determine optimal enrollment numbers, intervention models, dosing strategies, and blinding techniques. - Eligibility Criteria
Utilise AI to design detailed inclusion/exclusion criteria, improving participant selection. - Site Selection
Identify ideal site numbers and locations, and recommend the most relevant countries, investigators, and CROs. - Outcome Measures
Pinpoint key primary and secondary endpoint measures to track trial progress effectively. - Advanced Forecasting
Predict patient dropout rates, trial duration, and potential adverse events, allowing adaptation based on patient levels and budget constraints.
Additional User Benefits
Global Applicability
TrialKey supports clinical trials globally, including drug trials, medical devices, alternative therapies, and novel conditions, across all phases from preclinical to late-stage trials.
24/7 User Support
Clients can utilise the tool independently or opt for additional consultancy services provided by TrialKey’s team of experts. The platform also provides 24/7 live chat support.
Scalable
The platform’s scalable model caters to both small companies running a handful of trials annually and major companies running thousands of trials each year.
Users of TrialKey
Clinical Trial Researchers
Biostatistical validation to simulate trials, and optimise designs.
Trial Sponsors
Accelerate therapy development with TrialKey’s tailored recommendations
Investors
Leverage AI for substantial capital appreciation in the biotech sector
Request a free Preliminary Report
Our Partners
